Navigation Links
Dopamine used to prompt nerve tissue to regrow

When Yadong Wang, a chemist by training, first ventured into nerve regeneration two years ago, he didn't know that his peers would have considered him crazy.

His idea was simple: Because neural circuits use electrical signals often conducted by neurotransmitters (chemical messengers) to communicate between the brain and the rest of the body, he could build neurotransmitters into the material used to repair a broken circuit. The neurotransmitters could coax the neurons in the damaged nerves to regrow and reconnect with their target organ.

Strange though his idea might have seemed to others in his field, Wang, an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, discovered that he could integrate dopamine, a type of neurotransmitter, into a polymer to stimulate nerve tissues to send out new connections. The discovery is the first step toward the eventual goal of implanting the new polymer into patients suffering from neurological disorders to help repair damaged nerves. The findings were published online the week of Oct. 30 in the Proceedings of the National Academy of Sciences (PNAS).

"We showed that you could use a neurotransmitter as a building block of a polymer," said Wang. "Once integrated into the polymer, the transmitter can still elicit a specific response from nerve tissues."

The "designer" polymer was recognized by the neurons when used on a small piece of nerve tissue and stimulated extensive neural growth. The implanted polymer didn't cause any tissue scarring or nerve degeneration, allowing the nerve to grow in a hostile environment post injury.

When ready for clinical use, the polymer would be implanted at the damaged site to promote nerve regeneration. As the nerve tissue reforms, the polymer degrades.

Wang's team found that dopamine's structure, which contains two hydroxyl groups, is vital for the material's neuroactivity.
'"/>

Source:Georgia Institute of Technology


Page: 1 2

Related biology news :

1. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
2. Dopamine drug leads to new neurons and recovery of function in rat model of Parkinsons
3. Plants defy Mendels inheritance laws, may prompt textbook changes
4. PET/CT can identify new cancer lesions at early stage, allowing for prompt treatment
5. Plant defenses prompt bacterial countermeasure in the form of island DNA excision
6. Just like us, social stress prompts hamsters to overeat, gain weight
7. Renewed dolphin slaughter prompts new campaign
8. Malaria vaccine prompts victims immune system to eliminate parasite from mosquitoes
9. Wisconsin scientists grow critical nerve cells
10. Clam embryo study shows pollutant mixture adversely affects nerve cell development
11. Zebrafish may hold key to understanding human nerve cell development
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Dopamine used prompt nerve tissue regrow

(Date:6/24/2015)... 2015 Biometry authentication provider KeyLemon today ... solution one face in. Logo ... face in, entering the expanding biometric authentication market ... biometric answer to the password problem. With advanced ... with KeyLemon, one face in allows users to ...
(Date:6/23/2015)... Fla. , June 23, 2015 /PRNewswire/ ... management and authentication solutions, today announced enhanced functionality ... multi-factor authentication solution.  The enhancements build on ... of the DigitalPersona Altus platform and provide ... compatibility. In today,s environment of ...
(Date:6/17/2015)... and HILDEN, Germany , June 17, 2015 ... Frankfurt Prime Standard: QIA) today launched new Investigator ® ... laboratories in the United States . The ... analyze multiple key genomic markers (short tandem repeats or STRs) ... Sensor to evaluate the quality of DNA in each sample, ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
... at Memorial Sloan-Kettering Cancer Center (MSKCC) have shown for ... blood disorders may be inherited. Their research, published online ... genetic sequence abnormality that enhances the likelihood of acquiring ... diseases. The investigators carried out a genome-wide study ...
... (NIEHS), part of the National Institutes of Health (NIH), ... of Toxicology (SOT) meeting in Baltimore, Md. Scientists from ... NIEHS administers, as well as their grantees and collaborators, ... the field of toxicology. Why: The SOT Annual Meeting ...
... researchers at Kansas State,University, with collaboration from Epitopix ... against E. coli O157 in beef ... focus on the post-harvest food safety,aspect, whether it,s ... Thomson of,K-State,s College of Veterinary Medicine. Thomson is ...
Cached Biology News:Hear about emerging trends in toxicology research 2K-State researchers help Epitopix license the United States' first E. coli O157 vaccine for cattle 2
(Date:7/6/2015)... July 6, 2015  Approximately 1% of the population ... their chromosomes. These individuals are three times more likely ... in one of the nation,s leading medical journals by ... Canada.  Photo - http://photos.prnewswire.com/prnh/20150706/230685 ... (HHV-6) causes roseola (also known as "sixth disease") and ...
(Date:7/6/2015)... ... July 06, 2015 , ... Discovery of new biomarkers ... key drivers of the global molecular diagnostics market. BCC Research reveals in its ... new companion diagnostic tests will increase demand for inexpensive and accurate tests for ...
(Date:7/6/2015)... , July 6, 2015  Viveve Medical, Inc. ("Viveve") (OTCQB: VIVMF), ... Patricia Scheller , Viveve,s Chief Executive Officer, and Scott ... VirtualInvestorConferences.com on July 9, 2015. , , , ... , , , TIME:     , , , ... , , , http://tinyurl.com/viveve   , ...
(Date:7/6/2015)... July 6, 2015 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") ... agreement with Novella Clinical (Novella), to conduct ... with newly diagnosed glioblastoma. Novella is a full-service, global ... small to mid-sized oncology companies. The ICT-107 phase 3 ... US, Europe and ...
Breaking Biology Technology:Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 2Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation 3Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 2Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 3Viveve to Webcast Live at VirtualInvestorConferences.com 2Viveve to Webcast Live at VirtualInvestorConferences.com 3ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2
... Nokia,s new website, which provides innovative ways to interact with thought ... , ... San Francisco, CA (PRWEB) February 12, 2009 -- ... genetic testing service 23andme, says that as we further our understanding ...
... OriGene Technologies, Inc. ("OriGene") today announced it ... private equity financing. With this financing, OriGene completed ... Shenzhen P&A Biotech, a manufacturer and provider of ... this acquisition OriGene completes the establishment of its ...
... for the control of parasites in agriculture and medicine, today announced that ... will further its efforts to create solutions for one of the major ... ... (PREWB) February 11, 2009 -- Biotechnology firm Divergence, Inc., a world leader ...
Cached Biology Technology:Famed IT Investor and Director of 23andme Esther Dyson Identifies on IdeasProject.com Genetic Information as an Extremely Disruptive Force 2Famed IT Investor and Director of 23andme Esther Dyson Identifies on IdeasProject.com Genetic Information as an Extremely Disruptive Force 3OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China 2Divergence Raises $11.8 Million in Series C Financing 2Divergence Raises $11.8 Million in Series C Financing 3